Condensed tannins are wide-spread polyphenols with diverse ecological functions, including defense against herbivores and microbial pathogens. In poplar, condensed tannin synthesis is induced by a variety of biotic and abiotic stresses. The objective of this study was to determine the function of the R2R3 MYB transcription factor MYB115 in the regulation of condensed tannin synthesis. MYB115 was shown to be induced by wounding along with tannin biosynthetic genes and shows sequence similarity to characterized regulators of tannin synthesis in grape and persimmon suggesting that it functions in the regulation of condensed tannin synthesis. To analyze the function of MYB115, transgenic plants overexpressing MYB115 were generated and showed enhanced accumulation of condensed tannins and higher expression of flavonoid biosynthetic genes involved in condensed tannin biosynthesis compared to wild-type control plants. In promoter activation assays, MYB115 activated the promoter of a tannin-specific biosynthetic enzyme, anthocyanidin reductase. This suggests that MYB115 acts as a regulator of condensed tannin synthesis. MYB115 overexpressors showed additional changes to phenolic metabolism, including changes in levels of phenolic glycosides and hydroxycinnamic acids. These results indicate an important role of MYB115 in the regulation of the condensed tannin pathway in poplar. / Graduate / 0817 / 0307 / 0487 / frankla@uvic.ca

Tissue-resident macrophages (MΦ) such as microglia, Kupffer and Langerhans cells derive from Myb-independent yolk sac (YS) progenitors generated before the emergence of hematopoietic stem cells (HSCs). Myb-independent YS-derived resident MΦ self-renew locally, independently of circulating adult monocytes and HSCs. In contrast, adult blood monocytes as well as infiltrating, gut and dermal MΦ derive from Myb-dependent HSCs and are less proliferative. These findings are derived from the mouse, using gene knock-outs and lineage tracing, but their applicability to human development has not been formally demonstrated. Here I use a human pluripotent stem cell (hPSC) differentiation model of hematopoiesis, capable of monocyte/MΦ production over prolonged periods of time, as a tool to investigate human mononuclear phagocyte ontogeny. Using a transcriptomic approach I showed that hiPSC-derived monocytes/MΦ (iPS-Mo/MΦ) produced early in differentiation (first weeks) are more proliferative and less immunologically mature than iPS-Mo/MΦ produced at a later time point. I therefore hypothesised either that iPS-Mo/MΦ only become fully mature after several weeks of differentiation or that there are two developmentally distinct waves of MΦ produced over time. By comparing the transcription profile of iPS-Mo/MΦs to that of primary adult blood monocytes and fetal microglia I then showed that early and late iPS-Mo/MΦs were transcriptionally closer to fetal microglia than to adult blood monocytes. To further investigate if iPS-Mo/MΦs are indeed of the same developmental origin as MYB-independent MΦ such as microglia, I used a CRISPR-Cas9 knock-out strategy to show for the first time, that human iPS-Mo/MΦs develop in a MYB-independent, RUNX1 and SPI1 (PU.1)-dependent fashion. This result makes human iPS-Mo/MΦs developmentally related to, and a good model for, MYB-independent tissue-resident \Macros such as alveolar and kidney MΦs, microglia, Kupffer and Langerhans cells. Interestingly, while MYB was not required for the generation of iPS-Mo/MΦs, its knock-out resulted in an increase in iPS-Mo/MΦ production. To investigate this increase I developed two methods for quantifying the differentiation bottleneck occurring during hiPSC differentiation to iPS-Mo/MΦs. Those techniques highlighted a potential increase in progenitor cell generation in MYB KO cells and thus lay foundation to improve our technical understanding of EB differentiation and will enable enhanced manipulation of the EB model.

Flavonoids are important and ubiquitous secondary metabolites and are known to participate in various developmental and stress response processes in plants. Common flavonoids include anthocyanins, proanthocyanidins and flavonols. This thesis aims to determine, at the molecular level, how the biosynthesis of flavonoids, in particular the proanthocyanidins, is regulated in poplar. Poplars accumulate large amount of flavonoids and the major flavonoid biosynthetic genes in poplar have been identified. Flavonoid biosynthesis is known to be regulated by MYB transcription factors. Previous work had identified MYB134 as a key regulator of proanthocyanidin synthesis in poplar. Here I describe experiments on five additional genes encoding MYB activators (MYB115 and MYB117), MYB repressors (MYB165 and MYB194), and one bHLH cofactor (bHLH131) as possible flavonoid regulators in poplar. The objective of this work is to determine the in planta functions of these new flavonoid regulators using reverse genetic methods, phytochemical and transcriptome analysis, to identify their target genes and to determine how these transcriptional regulators interact using promoter transactivation and yeast two- hybrid assays. MYB115 was identified as a second proanthocyanidin regulator. Similar to the effects of MYB134, overexpression of MYB115 in poplar led to increased proanthocyanidin content and upregulated flavonoid biosynthesis genes, but reduced the accumulation of salicinoids. Overexpression of repressor type MYBs, MYB165 or MYB194 led to reduced anthocyanin, salicinoid and hydroxycinnamic ester accumulation in leaves, while reducing proanthocyanidin content in roots. Transcriptome analysis demonstrated the downregulation of most flavonoid genes in these transgenics, as well as some shikimate pathway genes, confirming the broad repression function on the phenylpropanoid pathway. By contrast, MYB117 encodes an anthocyanin activator, and was shown to be specific to this branch of the flavonoid pathway. Overexpression of MYB117 in transgenic poplar increased accumulation of anthocyanin in all tissues, resulting in red poplar plants. One bHLH cofactor, bHLH131 was shown to interact with both MYB activators and repressors and required by MYB activators to activate flavonoid gene promoters. This indicate an important role of bHLH131 in the flavonoid biosynthesis. Proanthocyanidin MYB activators, MYB134 and MYB115 could activate each other. This indicates a positive feedback loop of proanthocyanidin MYB activators. Interestingly, repressor MYB165 suppressed expression of other flavonoid MYB repressors including MYB194 and MYB182, which shows a negative feedback loop of MYB repressors. The expression of bHLH131 was also regulated by MYB activators and repressors. These results reveal the complex interaction between these regulators. iii iv Unexpectedly, overexpression MYB134, MYB115 or MYB117 poplars upregulated flavonoid 3’5’-hydroxylase and cytochrome b5 genes, and lead to enhanced flavonoid B- ring hydroxylation and an increased proportion of delphinidin, myricetin Overexpression of flavonoid 3’5’-hydroxylase in poplar confirmed its function in enhancing B-ring hydroxylation. However, overexpression of cytochrome b5 in flavonoid 3’5’-hydroxylase- overexpressing plants did not further increase flavonoid B-ring hydroxylation. Thus its role in flavonoid B-ring hydroxylation remained unclear. These results show that flavonoid MYBs could also alter flavonoid structure. Together, these studies outline the complex regulatory network formed by flavonoid MYB activators and repressors, and bHLH cofactors controlling both flavonoid accumulation and structure. / Graduate / 2020-12-04

La leucémie aiguë à basophile du Nourrisson est un sous-type rare de leucémie aiguë myéloïde.Notre équipe avait précédemment participé à la caractérisation moléculaire de la translocationrécurrente t(X;6)(p11;q23) générant un gène de fusion MYB-GATA1 chez les nourrissons desexe masculin. Pour mieux comprendre son rôle, le facteur de transcription MYB-GATA1résultant de cette fusion a été exprimé dans des cellules progénitrices de l’hématopoïèsehumaine, CD34+ avant xénogreffe chez des souris immunodéficientes. Les cellules exprimantMYB-GATA1 présentaient une augmentation de l’expression des marqueurs d’immaturité(CD34), des marqueurs de la lignée granuleuse (CD33, CD117) et des signes de différenciationbasophile (CD203c, FcƐRI). Des cellules de lignée UT-7 ont également montré descaractéristiques de différenciation basophile après transduction par MYB-GATA1. Une analysetranscriptomique a permis de mettre en évidence 9 gènes dérégulés à la fois par la présence deMYB-GATA1 et par la différenciation basophile. L’augmentation de l’expression de 3 de cesgènes (CCL23, IL1RL1 et NTRK1) a été confirmée en RT-PCRq dans des cellules CD34+transduites avec MYB-GATA1. L’IL-33 (Interleukine 33) et le NGF (Nerve Growth Factor),les ligands respectifs de IL1RL1 et NTRK1, augmentent la différenciation basophile de cellulesUT-7 exprimant MYB-GATA1, démontrant l’importance de ces voies de signalisation dans ladifférenciation basophiles de cellules leucémiques et de cellules primaires de l’hématopoïèsehumaine CD34+. Enfin une expérience utilisant la luciférase a confirmé que MYB et MYBGATA1augmentaient l’activité des facteurs de transcription NTRK1 et IL1RL1 conduisant àl’acquisition de caractéristiques basophiles. Nos résultats soulignent ainsi l’importance desrécepteurs à l’IL-33 et au NGF dans la différenciation basophile des cellules normales etleucémiques. / Acute basophilic leukaemia (ABL) is a rare subtype of acute myeloblastic leukaemia. Wepreviously described a recurrent t(X;6)(p11;q23) translocation generating a MYB-GATA1fusion gene in male infants with ABL. To better understand its role, the chimeric MYB-GATA1transcription factor was expressed in CD34-positive hematopoietic progenitors which weretransplanted into immunodeficient mice. Cells expressing MYB-GATA1 showed increasedexpression of markers of immaturity (CD34), of granulocytic lineage (CD33, CD117) and ofbasophilic differentiation (CD203c, FcƐRI). UT-7 cells also showed basophilic differentiationafter MYB-GATA1 transfection. A transcriptomic study identified 9 genes deregulated by bothMYB-GATA1 and by basophilic differentiation. Induction of three of these genes (CCL23,IL1RL1 and NTRK1) was confirmed in MYB-GATA1-expressing CD34-positive cells byRTqPCR. IL-33 and NGF (Nerve Growth Factor), the ligands of IL1RL1 and NTRK1,respectively, enhanced the basophilic differentiation of MYB-GATA1-expressing UT-7 cells,thus demonstrating the importance of this pathway in basophilic differentiation of leukemiccells and CD34 positive primary cells. Finally, gene reporter assays confirmed that MYB andMYB-GATA1 activated NTRK1 and IL1RL1 transcription leading to basophilic skewing ofthe blasts. Our results highlight the role of IL-33 and NGF receptors in basophilic differentiationof normal and leukemic cells.

Un être humain adulte produit environ deux millions d’érythrocytes par seconde, à travers un processus connu sous le nom d’érythropoïèse. L’érythropoïèse est contrôlée par une balance entre prolifération et différenciation finement régulée. L’expression des gènes impliqués dans ces deux processus distincts, est régulée extrinsèquement (cytokines) et intrinsèquement (microenvirennement métabolique, facteurs de transcription). Les facteurs de transcription, fonctionnent sous forme de complexes multiprotéiques et contrôlent l’activité transcriptionnelle des cellules. Parmi eux, le complexe LDB1 joue un rôle clé dans la régulation de la balance prolifération/différenciation pendant l’érythropoïèse, puisqu’il contrôle l’expression des gènes impliquées dans ces deux processus. Au cours de mon doctorat, nous avons d’abord caractérisé les mécanismes moléculaires de la “pré-activation” des gènes de différenciation, également nommés marqueurs erythroides, dans les progéniteurs erythroides immatures. La pré-activation, est un état dans lequel, les gènes sont exprimés à un niveau basal très bas, permissif pour une activation significative pendant la différenciation. Nous avons ainsi montré que les répresseurs : ETO2, IRF2BP2 et NCOR1, interagissent avec le complexe LDB1, et lient ensemble les gènes des marqueurs erythroides et les répriment. Au cours de l’érythropoïèse, ces corépresseurs sont déstabilisés et LDB1 agit alors comme un activateur. En ce qui concerne les gènes de prolifération, nous avons observé que le complexe LDB1 est déstabilisé au niveau de ces loci pendant l’érythropoïèse. Afin d’étudier les mécanismes moléculaires de la répression génique des gènes de prolifération au cours de l’érythropoïèse, nous avons choisi d’étudier Myb, une cible du complexe LDB1, étudié auparavant dans le laboratoire. Nous avons testé trois facteurs : ZEB1, OGT et RNF12, en tant que candidats dans la répression de Myb. Nous avons montré que RNF12 est le seul facteur intervenant dans la transcription de Myb. RNF12 régule Myb probablement par une modification de complexes épigénétiques. / Every second about 2 million erythrocytes are produced in the adult human body, through a process called erythropoiesis. Erythropoiesis is controlled by a highly regulated balance between proliferation and differentiation. Expression of genes responsible for cell proliferation and differentiation is controlled external (such as cytokines) and internal (such as metabolic microenvironment and transcription factors). Transcription factors bind DNA and recruit co-factors generating transcriptional complexes. The LDB1 complex has a key role in the balance between erythroid proliferation vs. differentiation, since it regulates genes involved in both processes. During my Ph.D., we investigated the molecular mechanisms that LDB1 employs to regulate genes with divergent function. We first showed that in erythroid progenitors, differentiating genes, also known as erythroid markers, are primed. Gene priming consists of genes expressed in low basal but significant levels in progenitors, which can rapidly be activated during differentiation. We showed that in progenitors, ETO2, IRF2BP2 and NCOR1, bind the LDB1 complex therefore generating a priming complex. During differentiation, binding of the repressive (ETO2-IRF2BP2-NCOR1) co-factors to the LDB1 complex, is destabilized and genes become active. In genes involved in erythroid proliferation, we observed that LDB1 is destabilized, a feature leading to gene silencing. We used Myb, as a model of gene silencing in the context of regulation by the LDB1 complex. We tested three transcription factors: ZEB1, OGT and RNF12, as candidates in gene silencing. Among these factors, only RNF12 regulates Myb expression, probably through modifications of epigenetic silencers (Polycomb/MLL).

Les composés phénoliques de la baie, et plus particulièrement les flavonoïdes (flavonols, tanins condensés, anthocyanes), constituent un des paramètres clés contrôlant la qualité organoleptique du raisin et du vin. Ils représentent également une source de molécules antioxydantes d’intérêt grandissant pour les industries pharmacologiques, agro-alimentaires et cosmétiques. De nombreux travaux réalisés sur les plantes modèles ont démontré que la régulation de la voie de biosynthèse des flavonoïdes est essentiellement gouvernée par des facteurs de transcription de type MYB, bHLH et des protéines de type WD40. Chez la Vigne (Vitis vinifera L.), plusieurs facteurs de transcription de type MYB régulant la voie des anthocyanes et/ou des tanins condensés ont déjà été identifiés. Cependant, aucun facteur de transcription de type bHLH ou WD40 n’a encore été caractérisé. Différentes approches ont été mises en œuvre pour identifier de nouveaux régulateurs de la voie des flavonoïdes chez la Vigne. Dans un premier temps, le facteur de transcription VvMYB5b a été utilisé comme appât dans une approche de double hybride non ciblé chez la Levure (Saccharomyces cerevisiae). Dans un deuxième temps, le promoteur d’un gène codant une enzyme centrale de la voie de biosynthèse des flavonoïdes, VvDFR, a été choisi afin de développer une approche de simple hybride non ciblé chez la Levure. Enfin, une approche ciblée vers des « gènes candidats » a permis l’identification des facteurs de transcription de type bHLH VvMYC1 et VvMYCA1. Le profil d’expression de VvMYCA1 correspond à celui de l’accumulation des tanins condensés dans la pellicule, et celui de VvMYC1 corrèle avec le profil de synthèse des flavonols, des anthocyanes et des tanins condensés dans la baie de raisin, ainsi que dans les inflorescences. De plus, VvMYC1 peut interagir avec différents partenaires MYB de Vigne régulant la synthèse des anthocyanes et/ou des tanins condensés, à la fois dans la Levure mais également in planta, où l’interaction VvMYC1/VvMYBs affecte l’expression de gènes structuraux tels que l’UFGT et l’ANR. Cette interaction induit une synthèse d’anthocyanes, aussi bien en système homologue qu’en système hétérologue (Tabac et Arabidopsis). Enfin, des essais complémentaires impliquant le promoteur de VvMYC1 ont permis de démontrer que VvMYC1, en interagissant avec VvMYBPA1, peut moduler sa propre expression in vivo. / Phenolic compounds, and more specifically flavonoids (flavonols, condensed tannins and anthocyanins), are key components of the grapevine and wine quality. Because of their antioxidant activities, these compounds are of interest in pharmacological and cosmetic industries, as well as being beneficial to the human diet. Previous work on model plants showed that the flavonoid pathway was mainly regulated by the MYB and bHLH transcription factors, and WD40 proteins. In the grapevine (Vitis vinifera L.), only MYB regulators have been identified until now, and no bHLH or WD40 have been characterised. In this work, several approaches were used to identify new transcription factors involved in grapevine flavonoid biosynthesis. Firstly, the VvMYB5b protein was used as a bait in a large scale two hybrid experiment in yeast (Saccharomyces cerevisiae). Secondly, the promoter of the VvDFR gene, coding a central enzyme of the flavonoid pathway, was chosen to conduct a large scale one hybrid experiment, also in yeast. Finally, a “gene candidate” approach allowed identification of the bHLH transcription factors VvMYC1 and VvMYCA1. VvMYCA1 expression profile in berry skin and seeds correlates with condensed tannins synthesis, whereas VvMYC1 transcript accumulation in these tissues and the grapevine inflorescence correlates with condensed tannins, anthocyanins and flavonols accumulation. In yeast, VvMYC1 could physically interact with different MYB partners regulating the anthocyanin or the condensed tannins biosynthesis. This interaction was confirmed by transient promoter assays in grape cell suspensions, where co-expression of VvMYC1 with specific MYB partners activated the UFGT and ANR promoters. Likewise, this interaction induced anthocyanin accumulation in grape cells, as well as in tobacco leaves and Arabidopsis. Eventually, additional transient promoter assays revealed that VvMYC1 is involved, with VvMYBPA1, in feedback regulation of its own expression.

In jeder menschlichen Zelle entstehen täglich ca. 10.000 – 150.000 endogene DNA Schäden. Eine Anhäufung dieser Läsionen kann zu genetischer Instabilität führen und dadurch zur Krebsentwicklung beitragen. Daher ist eine schnelle DNA Schadensantwort nötig, um schwerwiegende Folgen für die Zelle zu vermeiden. Da bekannt ist, dass der Multiproteinkomplex LINC (auch humaner dREAM-Komplex genannt) an der transkriptionellen Regulation mitotischer und G2-spezifischer Gene beteiligt ist, sollte in dieser Arbeit seine Beteiligung an der DNA Schadensantwort genauer untersucht werden. In der vorliegenden Arbeit wird gezeigt, dass in normal wachsenden Zellen B-MYB an den LINC-Kernkomplex bindet, welcher sich aus 5 Proteinen zusammensetzt: LIN-9, LIN-54, LIN-52, LIN-37 und RbAp48. Treten DNA Schäden auf, dissoziiert B-MYB vom LINC Kernkomplex wobei gleichzeitig die Bindung von p130 und E2F4 an LINC induziert wird. Zusätzlich konnte gezeigt werden, dass der Signalweg, der die LINC Umlagerung vermittelt, sowohl p53- als auch p21-abhängig ist. p53 negative Zellen können nach Schädigung der DNA weder einen G1 Block induzieren noch einen G2 Block langfristig aufrechterhalten. Eine Erklärung für diese Schwächung des G2 Arrests liefern Daten dieser Arbeit: Da in DNA geschädigten p53 -/- Zellen keine LINC Umlagerung beobachtet werden kann und zusätzlich B-MYB verstärkt an LINC und die Zielpromotoren bindet, kommt es zu einer erhöhten G2/M Genexpression. Dies resultiert häufig in einem verfrühten Wiedereintritt in den Zellzyklus („checkpoint adaptation“). Eine Daten-Analyse primärer Brustkrebstumore zeigte außerdem, dass erhöhte B-MYB Genexpressionslevel mit einer erhöhte Rückfallgefahr und einer schlechten Prognose korrelieren, was möglicherweise auf die Funktion von B-MYB während der „checkpoint adaptation“ zurückzuführen ist. Schlussendlich lassen die Ergebnisse dieser Arbeit vermuten, dass die Hemmung der B-MYB Funktion in solchen Tumoren, die p53 Mutationen tragen, die Wahrscheinlichkeit eines Behandlungserfolges vergrößern und die Wahrscheinlichkeit eines Rückfalls senken könnte. / Around 10.000 – 150.000 endogenous DNA damage-induced lesions occur in a human body per day and cell. Accumulation of unrepaired lesions can lead to aneuploidy and the loss of genomic integrity which in turn contributes to tumor formation. Therefore, an efficient DNA damage response has to be initiated, in the end leading to cell cycle inhibition and induction of repair. Since it is known that a recently characterized human multiprotein complex named LINC (or human dREAM) together with B-MYB is involved in the regulation of G2/M gene expression (Plk1, cyclin B1, cdc2 etc.), its function in the DNA damage response was analyzed in this study. In growing cells B-MYB is associated to the LIN core complex which consists of 5 different proteins named LIN-9, LIN-54, LIN-52, LIN-37 and RbAp48. After induction of DNA damage B-MYB leaves the complex and binding of E2F4 and p130 to LINC is induced. Importantly, the upstream pathway leading to LINC rearrangement is dependent on the activation of p53 and p21. Interestingly, p53 -/- cells solely have the potential to block in the G2 phase of the cell cycle, thereby making them vulnerable for errors during G2 arrest induction or maintenance. Here I demonstrate that LINC rearrangement is absent in p53 -/- cells and that B-MYB/LINC binding to target gene promoters is increased. This in turn leads to an increased G2/M gene expression after DNA damage induction and triggers premature cell cycle re-entry (checkpoint adaptation). Significantly, B-MYB expression is increased in p53 mutated primary breast cancer tumors and correlates with poor prognosis and reoccurrence probably due to its function in checkpoint adaptation. This study gives evidence that inhibition of B-MYB gene expression or B-MYB function in p53 mutant tumors could be a good choice for adjuvant therapy.

In this dissertation, the formation of unusual G-quadruplexes in the critical regions of the c-myb and hTERT promoters for control of promoter activity was investigated.The c-myb promoter contains three copies of an almost perfect (GGA)4 sequence. We demonstrate that the each (GGA)4 repeat forms a tetrad:heptad G-quadruplex and any two of the three can intramolecularly dimerize to form T:H:H:T G-quadruplexes. The three T:H:H:T G-quadruplex combinations are of differing degrees of stability and can be further stabilized by G-quadruplex interactive compounds. We also demonstrate that the c-myb G-quadruplex forming region is a critical transcriptional regulatory element and interacts with various nuclear proteins including MAZ (Myc Associated Zinc finger protein). The data from luciferase reporter assay show that the c-myb GGA repeat region plays dual roles as a transcriptional activator and an inhibitor by serving as binding sites for the activators and by forming G-quadruplex structures in the region, respectively. Furthermore, we show that MAZ is a transcriptional repressor of the c-myb promoter and binds to both the double-stranded and T:H:H:T G-quadruplex-folded conformations of the GGA repeat region of the c-myb promoter.The hTERT core promoter contains a G-rich region of 12 consecutive G-tracts, which includes three critical Sp1 binding sites. Although this G-rich region has the potential to form multiple G-quadruplexes, our investigation on the full-length G-rich sequence demonstrate that the G-rich region forms a unique G-quadruplex structure in which two tandem intramolecular G-quadruplex structures are present, consisted of one G-quadruplex formed by the G-tracts 1-4 and the other formed by the G-tracts 5, 6, 11, and 12. We also demonstrate that the latter unusual structure contains a 26-base middle loop that likely forms a hairpin structure and is more stable than the other conventional G-quadruplex. Significantly, the formation of this unusual tandem G-quadruplex structure in the full-length will disable all three critical Sp1 binding sites, which will dramatically downregulate hTERT expression. G-quadruplex formation in the hTERT promoter suggests that the effect of G-quadruplex interactive ligands on telomerase inhibition and telomere shortening may be exerted by the direct interaction between the hTERT G-quadruplex structure and the ligands.

B cell development is a carefully orchestrated process involving many transcription factors acting in concert with cytokine signals, particularly IL-7. The transcription factor c-Myb has long been implicated in B cell development, however surprisingly little is known about the function of c-Myb in B cell progenitors. I have used several mouse models of c-Myb deficiency to investigate the role of c-Myb in the B cell lineage. Conditional deletion of c-Myb in early B cell progenitors using mb-1Cre (c MybΔmb1/Δmb1) leads to a striking lack of B cells from the pre-pro-B cell stage onwards, demonstrating that c-Myb is absolutely required for B cell development. Mice homozygous for a hypomorphic allele of c-Myb (c MybPlt4/Plt4) also display a severe reduction in B cells; in these mice, defects in lymphoid development can be detected within the multipotent progenitor compartment of bone marrow. c-Myb activates transcription via coactivator proteins, particularly CBP and p300. Mice bearing a point mutation in p300 (p300Plt6/Plt6) that inhibits the interaction of p300 with c Myb display a partial block in B cell development, highlighting the importance of the c Myb-p300 complex for B cell development. Together, these mice demonstrate that c-Myb regulates B cell development by functioning both in multipotent progenitor cells and directly in B cell progenitors. In addition, I show that the B-lymphopenia in c-Myb deficient mice is related to a profound defect in IL-7 signalling. IL-7 normally stimulates the proliferation, survival and differentiation of B cell progenitors, however pro-B cells from c-MybPlt4/Plt4 and c MybΔmb1/Δmb1 mice fail to respond to IL 7. Expression of the IL-7Rα chain is reduced on pro-B cells from c MybPlt4/Plt4 and c-MybΔmb1/Δmb1 mice, suggesting that Il7r may be a c-Myb target gene in B cells. Reporter gene assays show that c-Myb can activate the Il7r promoter in synergy with the transcription factor Pu.1. Overall, this work demonstrates that c-Myb is essential for early B cell development and plays a critical role in linking cytokine signals to the transcription factor networks in B cell progenitors.

Thesis (Ph. D.)--Cornell University, 1989. / Vita. Includes bibliographical references.